| 06 Apr, 02:38 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Dislcosure letter under Regulation 11(5) of The Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | bse |
| 01 Apr, 07:07 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 01 Apr, 07:03 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Cessation | bse |
| 01 Apr, 06:57 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 01 Apr, 06:41 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr. Chirayu Amin as Executive Chairman of the company w.e.f. April 01, 2026. | nse |
| 01 Apr, 06:38 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange that Mr. Chirayu Amin has Relinquished the position of Chief Executive Officer of the company w.e.f. April 01, 2026. | nse |
| 01 Apr, 06:25 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding Re-Appointment of Mr. Pranav Amin as Managing Director of the company w.e.f. April 01, 2026. | nse |
| 01 Apr, 02:15 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 01 Apr, 02:11 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr. Rajkumar Baheti as Non- Executive Non Independent Director of the company w.e.f. April 01, 2026. | nse |
| 31 Mar, 08:58 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 31 Mar, 08:57 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about change in Management | nse |
| 27 Mar, 03:22 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 27 Mar, 03:19 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 27, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Paroxetine Extended-Release Tablets USP, 12.5 mg.". | nse |
| 09 Mar, 07:51 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about General Updates - Incorporation of Subsidiary | nse |
| 09 Mar, 07:49 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Incorporation Of Subsidiary | bse |
| 06 Mar, 09:05 am | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 06, 2026, titled "Alembic Pharmaceuticals Reports First Prescription Sale of Pivya® (pivmecillinam) Following US Commercial Launch through Alembic Therapeutics LLC". | nse |
| 06 Mar, 09:03 am | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 26 Feb, 10:44 am | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 26, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Lamotrigine Orally Disintegrating Tablets USP, 25 mg, 50 mg, 100 mg and 200 mg". | nse |
| 26 Feb, 10:42 am | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 24 Feb, 02:30 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 24 Feb, 02:29 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 24, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Efinaconazole Topical Solution, 10%". | nse |
| 18 Feb, 10:59 pm | — | … | Completion of United States Food and Drug Administration inspection atAlembic Pharmaceuticals Limited Injectable Facility (F-3) at Karakhadi | nse |
| 11 Feb, 07:11 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 11 Feb, 07:06 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Transcript | nse |
| 06 Feb, 11:31 am | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Alembic Pharmaceuticals Limited announces USFDA Final Approval for Carbidopa, Levodopa and Entacapone Tablets.". | nse |
| 06 Feb, 11:31 am | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 05 Feb, 07:26 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Link of Recording | nse |
| 05 Feb, 07:26 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 05 Feb, 04:15 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 05 Feb, 03:57 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr. Raj Kumar Baheti (DIN: 00332079) as Non-Executive Non-Independent Director of the company w.e.f. April 01, 2026. | nse |
| 05 Feb, 03:12 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 05 Feb, 03:12 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation | nse |
| 05 Feb, 02:22 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Unaudited Financial Results For Quarter And Nine Months Ended 31St December, 2025 | bse |
| 05 Feb, 02:16 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 05 Feb, 02:13 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 05 Feb, 02:08 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Press Release on the Unaudited Financial Results for the quarter and nine months ended 31st December, 2025". | nse |
| 05 Feb, 02:04 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation | nse |
| 05 Feb, 02:00 pm | — | … | Alembic Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025. | nse |
| 05 Feb, 02:00 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Board Meeting Outcome for Outcome Of Board Meeting | bse |
| 05 Feb, 01:57 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on February 05, 2026. | nse |
| 31 Jan, 07:08 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about change in Management | nse |
| 31 Jan, 07:08 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 27 Jan, 12:36 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 27 Jan, 12:36 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 27, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Difluprednate Ophthalmic Emulsion, 0.05%.". | nse |
| 20 Jan, 10:28 am | — | … | Alembic Pharmaceuticals Ltd - 533573 - Board Meeting Intimation for Unaudited Financial Results For The Quarter And Nine Months Ended 31St December, 2025 | bse |
| 12 Jan, 12:10 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 12, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for BosutinibTablets, 400 mg". | nse |
| 12 Jan, 12:07 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 18 Dec, 11:02 am | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 18, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Travoprost Ophthalmic Solution". | nse |
| 18 Dec, 11:00 am | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 16 Dec, 04:03 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |